Literature DB >> 35094018

Circadian rhythm modulates endochondral bone formation via MTR1/AMPKβ1/BMAL1 signaling axis.

Shaoling Yu1,2,3, Qingming Tang1,2,3, Guangjin Chen1,2,3, Xiaofeng Lu1,2,3, Ying Yin1,2,3, Mengru Xie1,2,3, Yanlin Long1,2,3, Wenhao Zheng1,2,3, Fengyuan Guo1,2,3, Longquan Shao4, Anbing Shi5, Lili Chen6,7,8.   

Abstract

The circadian clock is a master regulator in coordinating daily oscillations of physiology and behaviors. Nevertheless, how the circadian rhythm affects endochondral ossification is poorly understood. Here we showed that endochondral bone formation exhibits circadian rhythms, manifested as fast DNA replication in the daytime, active cell mitosis, and matrix synthesis at night. Circadian rhythm disruption led to endochondral ossification deformities. The mechanistic dissection revealed that melatonin receptor 1 (MTR1) periodically activates the AMPKβ1 phosphorylation, which then orchestrates the rhythms of cell proliferation and matrix synthesis via destabilizing the clock component CRY1 and triggering BMAL1 expression. Accordingly, the AMPKβ1 agonist is capable of alleviating the abnormity of endochondral ossification caused by circadian dysrhythmias. Taken together, these findings indicated that the central circadian clock could control endochondral bone formation via the MTR1/AMPKβ1/BMAL1 signaling axis in chondrocytes. Also, our results suggested that the AMPKβ1 signaling activators are promising medications toward endochondral ossification deformities.
© 2021. The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35094018      PMCID: PMC8991200          DOI: 10.1038/s41418-021-00919-4

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   12.067


  1 in total

1.  Circadian BMAL1 regulates mandibular condyle development by hedgehog pathway.

Authors:  Shaoling Yu; Qingming Tang; Mengru Xie; Xin Zhou; Yanlin Long; Yanling Xie; Fengyuan Guo; Lili Chen
Journal:  Cell Prolif       Date:  2019-11-20       Impact factor: 6.831

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.